← Eichor
Study identifier: NCT06285292 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective and Comparative Evaluation of a Medical Device Composed of a Perineal Probe Connected to a Mobile Application in the Management of Stress Urinary Incontinence.

Condition: Urinary Incontinence  ·  Sponsor: Nantes University Hospital

PhaseNA
Planned participants138
Who can joinFemale, 18 Years to 60 Years
Healthy volunteersNo

About this study

Stress urinary incontinence (SUI) affects around 40% of women and has a major impact on quality of life. The gold standard for the treatment of SUI is pelvicfloor rehabilitation, but this presents constraints in terms of availability of healthcare professionals, as well as organization and travel for patients. Innovative devices offer self-training exercises for the pelvicfloor, thus promoting motivation and adherence to treatment. The hypothesis of this study is to prove that the use of a pelvicfloor medical device combined with 2 rehabilitation sessions is not inferior to pelvic-perineal rehabilitation.

This description comes directly from the study's public registry record.

Talk to the study team

Thibault THUBERT, PHD  ·  02.53.48.24.43  ·  thibault.thubert@chu-nantes.fr

Selma EL ANDALOUSSI, manager  ·  02.53.48.28.52  ·  selma.elandaloussi@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de NantesNantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06285292